Keith Orford, Senior VP, CLINICAL DEVELOPMENT at Calithera Biosciences, Inc. (CALA), sold 1,252 shares at $6.00 ($8K) on 2018-10-11, disclosed to the SEC on 2018-10-15.
Scheduled sale ($8k) by Senior VP, CLINICAL DEVELOPMENT under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CALA | SELL | 2020-12-18 | $15K | — | Filing → |
| CALA | SELL | 2020-02-24 | $24K | — | Filing → |
| CALA | SELL | 2019-12-26 | $18K | — | Filing → |